Hanania, Nicola A <br/><br/>
Efficacy and safety of nebulized formoterol as add-on therapy in COPD patients receiving maintenance tiotropium bromide: Results from a 6-week, randomized, placebo-controlled, clinical trial.  [electronic resource] 

 -  Drugs  Jun 2009 
 - 1205-16 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1179-1950 
<br/><br/><label>Standard No.: </label>10.2165/00003495-200969090-00005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenal Cortex Hormones--therapeutic use<br/>Adrenergic beta-Agonists--adverse effects<br/>Adult<br/>Aged<br/>Albuterol--therapeutic use<br/>Area Under Curve<br/>Bronchodilator Agents--adverse effects<br/>Drug Therapy, Combination<br/>Dyspnea--complications<br/>Ethanolamines--adverse effects<br/>Female<br/>Forced Expiratory Volume--physiology<br/>Formoterol Fumarate<br/>Humans<br/>Male<br/>Middle Aged<br/>Pulmonary Disease, Chronic Obstructive--drug therapy<br/>Quality of Life<br/>Scopolamine Derivatives--adverse effects<br/>Spirometry<br/>Tiotropium Bromide